Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 260

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 260
---
 Class B Ordinary Shares;
and (ii) the par value of the shares decreased from $1 each to $0.0001 each (collectively refer as the “Share Re-classification”).
The authorized share capital of the Company remained unchanged at $50,000. The 1 issued ordinary share held by LTO was reclassified as
10,000 Class A Ordinary Shares upon the Share Re-classification. The Company further allotted and issued 8,990,000 Class A Ordinary Shares
at $899 and 1,000,000 Class B Ordinary Shares at $100, respectively to LTO. On September 10, 2024, certain strategic investors acquired
4,320,000 Class A Ordinary Shares and 480,000 Class B Ordinary Shares, respectively.

Holders of Class A Ordinary Shares and Class
B Ordinary Shares shall vote together as a single class on all resolutions of the shareholders and have the same rights except each Class
A Ordinary Share shall entitle its holder to one (1) vote and each Class B Ordinary Share shall entitle its holder to fifteen (15) votes.
Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof but Class
A Ordinary Shares are not convertible into Class B Ordinary Shares.

The Company considered the above transactions
as a part of the Company’s recapitalization prior to completion of its initial public offering, the Company has retroactively restated
all shares and per share data for all the periods presented.

On March 31, 2025, the Company recorded constructive
dividends in the amounts of $983,560 through reductions in the amount due from Mr. To. The Company declared cash dividends $325,078 during
the year ended March 31, 2024.

Note 10 – Segment reporting

ASC 280, “Segment Reporting”,
establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational
structure as well as information about geographical areas, business segments and major customers in financial statements for details
on the Company’s business segments. The Company uses the “management approach” in determining reportable operating
segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision
maker, the Chief Executive Officer, for making operating decisions and assessing performance as the source for determining the Company’s
reportable segments. The chief operating decision maker reviews operation results by revenue, gross profit, operating expenses,